Meditoxin Botox Botulinum Toxin Type A 100IU  Features of our Botulium Toxin Type A

Meditoxin is botulinum A developed by Medy Tox Korea Limited that approved by KDA on 2004 which had been proved a better effect than Botox .

The most common complications following injection include bruising at the injection site, mild headache, dry eye, drooping eyelids and uneven look of skin. Most of these results are temporary, undesired effects will fade and then disappear over time.

Adverse effects are higher when treating medical ailments, a combination of the higher doses administered and higher risk factors associated with the specific illness being treated. Rarely, it can cause spread beyond the site of injection. If it travels to the respiratory muscles, respiratory paralysis can occur.

Duration of effects:

The effect of Botox  treatment lasts for 4-6 months. The treatment needs to be repeated after the effect wears off. Repeated treatments do not have any harmful effects.

Adverse effects:

Botox  when administered in the right areas in correct dosage does not cause any harm. The safety record for this treatment is high. Under correction can happen and can be easily corrected.

Usage of Botox ® for unapproved indications carries higher chance of adverse effects like drooping of lip and facial muscle weakness. Since effect of Botox is temporary, any adverse effect also reverses in that time.

Advantages:

Botox  is a non surgical treatment for treatment of age related changes on the face. The treatment takes less than 20 minutes and effects are visible in 3-6 days time.